Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

US Healthcare Providers Ishares ETF (NY: IHF )

52.24 -0.27 (-0.51%)
Streaming Delayed Price Updated: 3:20 PM EDT, May 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about US Healthcare Providers Ishares ETF

April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market
Performance in April 2024: Utilities lead, real estate lags. S&P 500, Nasdaq 100, Dow Jones Industrial Average, small-cap and large-cap indices all decline. 
Via Benzinga
Topics Stocks
Exposures US Equities
GDP Growth Slows In Q1: 5 ETFs To Invest In
Investors should bet on defensive areas that will likely see growth even if the economy slows down. These include sectors like utilities, real estate, healthcare, and consumer staples, as well as... 
Via Talk Markets
Topics ETFs Economy
Exposures Economy
3 Weight-Loss ETFs to Profit From the Obesity Drug Boom
Leverage Oprah's shift to prescription weight solutions with Weight-Loss ETFs, targeting companies leading in obesity treatment. 
Via InvestorPlace
Topics ETFs
Momentum Shifts Back To Tech Stocks As Healthcare Lags In 2024
Small Cap traders are taking a break in 2024 as XBI is down 2.51% YTD. 
Via Talk Markets
5 Secret Santa ETFs That Might Surprise You This Christmas
Wall Street has been sizzling hot this holiday season. This is likely to continue, given that the Santa Claus rally is on the way. Against such a backdrop, there are some hidden gems which could... 
Via Talk Markets
Topics ETFs
Mark Cuban's Cost Plus Drugs Gets Medication Elon Musk Asked About 6 Months Ago: 'Still Ready To Save Tesla, SpaceX And X a F**kton of Money'
Cuban updated Musk, sharing a link to purchase Ivermectin on Cost Plus Drugs' website. 
Via Benzinga
Healthcare Portfolio Focus Stocks
The macro news has been a steady headwind with rising rates offering 5% risk-free treasury yields. 
Via Talk Markets
Large Cap Biopharmaceuticals-Core Holdings For Your Healthcare Portfolio Until M&A Action Picks Up
Healthcare has not been a strong sector in 2023. Despite its history of being defensive in turbulent times the sector has underperformed as higher rates curb buyers sentiment. 
Via Talk Markets
Healthcare Playbook Revisited - Growth Plus Value
Despite concerns about rising healthcare costs and ever more expensive technology for treatment encompassing drugs, devices, and data management, still innovative medicine marches on. 
Via Talk Markets
4 Million People Lost Medicaid In 3 Months, Will Reach 15 Million Before The Election — How Is This Affecting Biden's Presidential Bid?
Via Benzinga
3 Health Insurance Stocks Getting Killed by Rising Costs
These health insurance insurance stocks to avoid are likely to shed more value with healthcare costs rising at a frightening pace 
Via InvestorPlace
Tuesday Talk: Eggs Still In The Basket
Investors returned to the market Monday, after the Good Friday trading holiday, with most of their eggs still intact. The early Spring rally seems to be holding as the market prepares for Q1 banking... 
Via Talk Markets
Got $10,000? Buy These 2 Market-Beating ETFs for the Long Haul
These exchange-traded funds have soundly beaten the S&P 500 over the past 10 years. 
Via The Motley Fool
Invest In Defensive ETFs As Recession Fear Grows In 2023
Here are five ETFs that look like excellent choices amid recession warnings. 
Via Talk Markets
5 Defensive ETFs To Play As Recession Fears Grow
The Fed has been aggressive in bringing down inflation, which is near its highest level since the early 1980s. This has compelled investors’ flight to defensive sectors. 
Via Talk Markets
Investor Anxiety As Bear Market May Give Way To Recession
Most investors seem convinced that a significant near-term recession is inevitable and as the bear gets worse, cash may be the safest place for their money. We disagree and suggest other courses of... 
Via Talk Markets
5 Recession-Proof ETFs for Your Portfolio
Investors should stash their cash in some conventionally secure and recession-proof corners of the broad market. 
Via Talk Markets
Healthcare Stocks Lead the Way Up as the Market Fades
With inflation and energy costs soaring, the Fed ever threatening with higher rates and headlines from the war in Ukraine investors are seeking more defensive positions. 
Via Talk Markets
5 ETFs to Add As Yield Curve Signals Recession
Here are some excellent ETF choices amid recession warnings. 
Via Talk Markets
U.S. Inflation At A 40-Year High: 4 Sector ETFs To Win
The annual inflation rate in the United States accelerated to 7.5% in January of 2022, marking a new high since June of 1982, well above market forecasts of 7.3%. Let's look at some of the sector ETFs... 
Via Talk Markets
U.S. Inflation Stands Tall: 4 Sector ETFs To Win
The annual inflation rate in the United States accelerated to 7% in December of 2021, marking a new high since June of 1982, in line with market expectations and compared with 6.8% in November. 
Via Talk Markets
5 Sector ETFs That Crushed the Market in December
December has been marked by heightened uncertainty and volatility for Wall Street. Inflationary fears and the fast spreading Omicron variant kept investors jittery, strong consumer confidence and... 
Via Talk Markets
5 Best-Performing ETFs of December
While most of the segments across the board have declined this month, a few are still in green with most of them from the defensive sectors like utilities, healthcare, and consumer staples. 
Via Talk Markets
Why WHO Did Not Recommend Convalescent Plasma Therapy For COVID-19
The World Health Organization said that it's not recommending the use of convalescent plasma as a treatment for COVID-19 for mild or severe cases. The treatment uses... 
Via Benzinga
Exposures COVID-19
Will Tech Stocks Derail the 3Q21 Earnings Rally?
S&P 500 equities continued to post robust 3rd quarter earnings reports, staying on track to grow EPS by 32.7% year-over-year. Over 84% of those reporting topped analysts’ forecasts. The damage from a... 
Via Talk Markets
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.